In a claustrophobic Martian colony where oxygen is a currency and medicine is a lottery, data analyst Kael spends his days managing the "Double Blind" study—a clinical rationing system that decides who receives life-saving treatment and who receives a placebo. The goal is scientific purity, but the reality is a slow death sentence for the colony's working class.
